SIA
STJ

Stancorp Investment Advisers’s St Jude Medical STJ Stock Holding History

Stancorp Investment Advisers’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$49K Sell
754
-1,806
-71% -$120K 0.02% 284
2014
Q4 		$166K Buy
+2,560
New +$165K 0.08% 181

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Stancorp Investment Advisers's STJ Position: Q1 2015 in Review

Stancorp Investment Advisers reduced its St Jude Medical (STJ) stake by 71% in Q1 2015, selling an estimated $120K and leaving 754 shares worth $49K. The position accounts for 0.02% of the portfolio, ranked #284.

Stancorp Investment Advisers first reported a position in STJ in Q4 2014 and has held it in 2 quarters since. The position peaked at $166K in Q4 2014. 590 funds tracked by Wall St. Rank hold STJ as of Q1 2015.

  • Stancorp Investment Advisers held 754 shares of St Jude Medical worth $49K as of Q1 2015.
  • Stancorp Investment Advisers sold 1,806 St Jude Medical shares in Q1 2015, an estimated $120K.
  • St Jude Medical made up 0.02% of Stancorp Investment Advisers's portfolio in Q1 2015, its #284 holding.
  • Stancorp Investment Advisers first reported a position in St Jude Medical in Q4 2014 and has held it in 2 quarters since.
  • Stancorp Investment Advisers's St Jude Medical position peaked at $166K in Q4 2014.
  • 590 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.